Decision Date2025-11-03
Product CodeMZP
Advisory CommitteeMI
DecisionSubstantially Equivalent
Device Summary
cobas HCV is a medical device manufactured by Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2025-11-03 under approval number K252484. The device is classified under product code MZP. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the cobas HCV?
cobas HCV is a medical device that received FDA 510(k) clearance on 2025-11-03. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K252484.
When was cobas HCV approved by the FDA?
cobas HCV received FDA 510(k) clearance on 2025-11-03, under approval number K252484.
What company makes cobas HCV?
cobas HCV is manufactured by Roche Molecular Systems, Inc..
What is the FDA product code for cobas HCV?
The FDA product code for cobas HCV is MZP.
Related Devices (Code: MZP)
K221007cobas HCVRoche Molecular Systems, Inc.
K233352Aptima HCV Quant Dx AssayHologic, Inc.
K252102Alinity m HCVAbbott Molecular, Inc.
PMA P100017Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virusAbbott Molecular, Inc.
PMA P150015Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virusRoche Molecular Systems, Inc.
PMA P060030Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virusRoche Molecular Systems, Inc.
Official Source
View on FDA Database →
Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.